Nerve Growth Factor Treatment and the Corneal Epithelium: Extracellular Vesicle‐Mediated Signaling
ABSTRACT Recombinant human nerve growth factor (NGF) is used to treat patients with impaired corneal wound healing. NGF exerts its effects through complex signaling processes initiated by the binding of one of two cell membrane receptors—TrkA and p75NTR. While the intracellular signaling pathways have been studied exte...